These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 35834821

  • 21. The historical development and an overview of contemporary keratoprostheses.
    Moshirfar M, Moody JJ, Barke MR, Martheswaran T, Thomson AC, Thomson RJ, Somani SN, Shmunes KM, Ronquillo YC, Hoopes P.
    Surv Ophthalmol; 2022; 67(4):1175-1199. PubMed ID: 35081413
    [Abstract] [Full Text] [Related]

  • 22. [Boston-keratoprosthesis : Preliminary experiences in 13 high-risk eyes from the Department of Ophthalmology of the University of Cologne].
    Schaub F, Hos D, Bucher F, Siebelmann S, Bachmann BO, Cursiefen C.
    Ophthalmologe; 2016 Jun; 113(6):492-9. PubMed ID: 26815458
    [Abstract] [Full Text] [Related]

  • 23. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D, Harissi-Dagher M.
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
    Geoffrion D, Hassanaly SI, Marchand M, Daoud R, Agoumi Y, Harissi-Dagher M.
    Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L, He X, Wang Q, Wu T, Liu A, Huang Y.
    Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
    [Abstract] [Full Text] [Related]

  • 28. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
    Senthil S, Mohamed A, Shanbhag SS, Durgam SS, Bagga B, Sangwan VS, Basu S.
    Cornea; 2022 May 01; 41(5):552-561. PubMed ID: 35383615
    [Abstract] [Full Text] [Related]

  • 29. [Keratoprostheses: Last Hope for the Most Severe Corneal Diseases].
    Bachmann B, Schaub F, Cursiefen C.
    Klin Monbl Augenheilkd; 2022 Sep 01; 239(9):1165-1179. PubMed ID: 35970191
    [Abstract] [Full Text] [Related]

  • 30. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY, Luo ZK, Chodosh J, Dohlman CH, Colby KA.
    Cornea; 2015 Mar 01; 34(3):264-70. PubMed ID: 25611395
    [Abstract] [Full Text] [Related]

  • 31. Frozen versus fresh corneal graft carriers in Boston keratoprosthesis surgery: 10-year outcomes.
    Sabeti S, Daoud R, Robert MC, Harissi-Dagher M.
    Can J Ophthalmol; 2022 Apr 01; 57(2):127-133. PubMed ID: 33781724
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R, Khoueir Z, Tsikata E, Chodosh J, Dohlman CH, Chen TC.
    Ophthalmology; 2017 Jan 01; 124(1):27-35. PubMed ID: 27538795
    [Abstract] [Full Text] [Related]

  • 34. Boston Keratoprosthesis Type 1: A Randomized Controlled Trial of Fresh versus Frozen Corneal Donor Carriers with Long-Term Follow-up.
    Muzychuk AK, Robert MC, Dao S, Harissi-Dagher M.
    Ophthalmology; 2017 Jan 01; 124(1):20-26. PubMed ID: 27566854
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.